Company Profile
Omega Funds is a global investment firm focused on identifying and supporting transformational companies in the life sciences sector. With a mission to improve human health, Omega Funds primarily invests in biopharmaceuticals, medical technologies, diagnostics, and digital health. The firm backs science-driven innovation and partners with entrepreneurs developing breakthrough products across the U.S. and Europe.
Founded in 2004, Omega Funds manages approximately $2 billion in assets under management. Its investment strategy spans early to late-stage private companies, as well as select public market opportunities. Omega’s portfolio includes a wide range of pioneering biotech firms tackling high-impact areas such as oncology, rare diseases, neurodegeneration, and gene therapies.
Headquartered in Boston, Massachusetts, with an additional presence in London, Omega Funds has built a reputation for deep sector knowledge, long-term support, and close collaboration with scientific founders. The firm often takes a hands-on approach, contributing to company strategy, governance, and clinical development to help build lasting and valuable businesses.
As a specialist life sciences investor, Omega Funds continues to pursue opportunities that align with its vision of delivering meaningful therapeutic innovation. Its global perspective and scientific focus make it a key player in the advancement of next-generation healthcare solutions.
News & Signals (0)
No linked news activity found for this company.